SKIN ATLAS · ACTIVE INGREDIENT · 4 MIN. READ

Transdermal Nanoparticle Drug Delivery Systems: Precision Transport into Deep Skin Layers

Transdermal nanoparticle drug delivery systems are nanoscale carrier vehicles – typically with diameters between 10 and 1,000 nanometers – that physically encapsulate cosmetic or pharmaceutical active ingredients and transport them specifically through the skin barrier. By controlled release in the target tissue, they increase the bioavailability of substances that would otherwise fail at the stratum corneum barrier. In the context of modern high-tech cosmetics, they are considered a key technology for delivering active ingredients deep into living tissue – epidermis and upper dermis.

Term and Origin

The term nanoparticle derives from the Greek nanos (dwarf) and the Latin particula (small particle). In formulation research, it refers to colloidal structures in the nanometer range, first described in the 1970s as liposomes in pharmaceutical research. The systematic application for transdermal drug delivery began in the 1990s, led by work from Bangham and later Gregoriadis on liposomal carriers. In cosmetics, nanoformulations became established from the early 2000s, when manufacturers began to protect unstable active ingredients such as retinol or vitamin C in lipid nanoparticles and to increase their penetration depth.

Regulation-wise, transdermal nanoparticles are a sensitive area in the European Union: The EU Cosmetics Regulation EU 1223/2009, since its amendment in 2013 (Article 16), obliges manufacturers to declare and notify the European Commission of all nanomaterials used in cosmetics. The INCI name must be marked with the suffix "[nano]" in the ingredient list – a transparency requirement that informs consumers about particle size. Scientific classification is provided by the Scientific Committee on Consumer Safety (SCCS) of the EU Commission, which regularly publishes opinions on individual nanomaterials in cosmetics.

Historically, nanotechnology in skincare products shares its roots with pharmaceutical nanomedicine, such as the liposomal doxorubicin formulation (Doxil®, FDA approval 1995) – a milestone that proved that nanocarrier systems can fundamentally alter drug profiles. The cosmetic industry adopted this principle, but without equating the biological barriers of the skin with those of the bloodstream; the stratum corneum represents a structurally and functionally unique penetration barrier.

Characteristics & Mechanism of Action

The skin has three potential penetration pathways for nanoparticles: the transcellular pathway (through corneocytes), the intercellular pathway (through the lipid matrix between corneocytes), and the transfollicular pathway (via hair follicles and sweat glands). The latter is particularly relevant for particles between 100 and 600 nm, as follicular openings represent effective entry points and perifollicular dendritic cells and Langerhans cells in the upper follicular infundibulum serve as immunological anchor points. Smaller particles under 50 nm can also partially penetrate the lamellar lipid structure of the stratum corneum.

Among the most commonly used nanocarrier systems in cosmetic formulations are: Liposomes (phospholipid bilayer vesicles, 50–400 nm), solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), polymeric nanoparticles based on PLGA or chitosan, and transfersomes – highly flexible vesicles with surfactant additives that actively penetrate the skin via hydrophilic pressure gradients. For active ingredients such as Bakuchiol, alpha hydroxy acids, or sensitive polyphenols, nanoencapsulation first provides protection against oxidation and photodegradation, and second, a delayed, controlled release (sustained release) in the target compartment.

Biochemically, nanoparticles exert their effect indirectly: They act as a reservoir that maintains the active ingredient concentration gradient over time. Release occurs through membrane fusion (liposomes), lipid diffusion (SLN/NLC), or enzymatic or pH-triggered degradation (polymeric systems). For antioxidants such as ferulic acid – a known synergist for vitamins C and E – this means that the biologically active concentration in the target tissue can be maintained significantly longer than with conventional topical application. Similarly, bioactive macromolecules such as exosomes, which are at the interface between nanomedicine and cosmetics, benefit from nanoparticulate protective shells that secure their membrane integrity until penetration.

Skincare Approach

In cosmetic practice, nanoparticle formulations are primarily used in serums, emulsions, and concentrated essences – galenic forms that, due to their thin consistency and high water content, promote penetration kinetics. When applied, the following formulation principles apply: Products containing nanoparticles should generally be applied to thoroughly cleansed skin, as sebum, oil, and residues can mechanically inhibit follicular infiltration – an argument for double cleansing as preparation. The application temperature also influences the lipid fluidity of the stratum corneum: Slightly warmed skin (e.g., after a warm cleansing step) shows increased membrane permeability and improved nanoparticle uptake.

When layering in the skincare routine, formulation science recommends applying nanoparticle serums before heavier occlusives like face creams or oils to maintain the concentration and moisture pressure towards the skin. A thin film of a balancing toner as a first layer can pre-hydrate the stratum corneum and promote swelling of the corneocytes, which facilitates the intercellular pathway for subsequent nanoparticles. For sensitive skin, special care is required: Polymeric nanoparticles based on chitosan show favorable biocompatibility profiles in the literature, while cationic formulations may have irritating potential.

In the context of chronobiologically optimized skincare, the timing of application gains additional relevance: Evening application synchronizes nanoparticulate active ingredient release with the skin's nocturnal repair phase, during which cell division rate, DNA repair enzymes, and growth factor secretion reach their daily maximum. This approach is also discussed in time-targeted chrono-peptide formulations, which link release kinetics to circadian tissue patterns. For consumers, the NATURFACTOR® Porcelain Skin Serum line and Blue Crystal Drops offer formulation approaches based on precise active ingredient availability in the skin.

Realistic Expectations

Transdermal nanoparticle systems demonstrably improve the penetration depth and bioavailability of active ingredients – this has been proven by numerous in-vitro and ex-vivo studies on human skin. Nevertheless, complete systemic absorption through intact skin is not the goal and not regulatorily desired for most cosmetic nanoformulations. The biological effect remains within the epidermis and papillary dermis; vascular penetration into the systemic circulation is highly unlikely with an intact skin barrier and particle sizes above 20 nm.

Visible improvements – such as increased skin glow, finer pores, or reduced wrinkles – are realistic with consistent use over a period of four to eight weeks, provided the encapsulated substance (e.g., retinol, peptides, antioxidants) has known efficacy. Nanoparticles potentiate the effect of the active ingredient; they do not replace it. Individual variation due to skin type, Fitzpatrick phototype, age-related changes in follicle density, and lipid matrix composition of the stratum corneum significantly influences penetration efficiency.

Regarding safety: The SCCS of the EU Commission evaluates nanomaterials in cosmetics on a case-by-case basis and has confirmed the safety of many common systems (e.g., nano zinc oxide, nano TiO₂ in sunscreens) for external application on intact skin. However, on damaged skin (eczema, psoriasis, barrier disorders), penetration depth can increase considerably; in such cases, dermatological consultation is recommended.

Frequently Asked Questions

Are nanoparticles in cosmetics safe?

For intact skin, the current scientific consensus is largely positive: Authorities like the SCCS of the EU Commission and the BfR in Germany have evaluated a multitude of cosmetic nanomaterials and have not detected systemically relevant absorption on intact skin. Crucially, regulatory notification is mandatory according to EU 1223/2009 Article 16, as is INCI labeling with "[nano]". Consumers can identify whether a product contains nanomaterials by checking the ingredient list.

Are liposomes different from other nanoparticles?

Yes, substantially. Liposomes are vesicles made of phospholipids with an aqueous core chamber – they can transport hydrophilic and hydrophobic active ingredients simultaneously and fuse with biological membranes. Solid lipid nanoparticles (SLN), on the other hand, consist of a lipid core that is solid at body temperature and lack an aqueous chamber, making them particularly suitable for lipophilic active ingredients. Nanostructured lipid carriers (NLC) combine solid and liquid lipids for increased loading capacity. Polymeric nanoparticles offer the most precise controlled release but are chemically more complex to produce. The choice of system depends on active ingredient polarity, desired release kinetics, and formulation stability.

Can I combine nanoparticle products with acid exfoliants?

Generally yes, but with caution: AHA acids and BHA change the skin's pH and can temporarily destabilize the lipid matrix of the stratum corneum, which increases the penetration depth of nanoparticles – which can be desirable or irritating depending on the active ingredient. Time-delayed layering is recommended: Acid preparations in the evening in a separate step, nanoparticle serums on alternating evenings or after the skin's pH has fully normalized (approx. 20–30 minutes after acid application).

Conclusion

Transdermal nanoparticle drug delivery systems represent one of the most scientifically sound approaches to increasing the efficiency of cosmetic active ingredients. They solve the fundamental formulation dilemma that the strongest barrier of the human body – the stratum corneum – repels precisely those active ingredients that are intended to work in deeper layers. Through encapsulation, penetration optimization, and controlled release, nanocarriers bridge this contradiction. For daily care, this means: Those who opt for nanoparticle-containing serums or essences invest in delivery precision – but only with maximum benefit if the encapsulated active ingredient itself is evidence-based, the formulation is stable, and the application routine is consistent. Ultimately, formulation quality matters more than the sheer number of ingredients. The EU labeling requirement for nanomaterials allows informed consumers to use this technology consciously and knowledgeably.

1. Müller R.H., Mäder K. & Gohla S. (2000). Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. European Journal of Pharmaceutics and Biopharmaceutics, 50(1), 161–177.
2. Patzelt A. & Lademann J. (2013). Drug delivery to hair follicles. Expert Opinion on Drug Delivery, 10(6), 787–797.
3. Nohynek G.J., Lademann J., Ribaud C. & Roberts M.S. (2007). Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety. Critical Reviews in Toxicology, 37(3), 251–277.
4. Sahle F.F., Gebre-Mariam T., Dobner B., Wohlrab J. & Neubert R.H.H. (2015). Skin diseases associated with the depletion of stratum corneum lipids and potential recovery strategies. Skin Pharmacology and Physiology, 28(1), 42–55.
5. Scientific Committee on Consumer Safety (SCCS) (2019). Guidance on the safety assessment of nanomaterials in cosmetics. SCCS/1618/20. European Commission, Brussels.
6. Benson H.A.E. & Watkinson A.C. (Eds.) (2012). Transdermal and Topical Drug Delivery: Principles and Practice. Wiley, Hoboken, NJ.